Showing results 1 - 10 of 38
One of the advantages of registering designs in the UK and Europe is that they are not substantively examined. This means it’s relatively inexpensive and quick to obtain a registration. Howe...
At GJE, we have experience in challenging and defending the validity of UK patents and patent revocation proceedings at the highest level. Our team of experts has acted for our clients in the Chancery...
All too frequently, a business discovers a competitor’s patent lurking in the wings, standing in the way of a new project or commercial product. However a very small percentage of those businesses...
The UKIPO’s official fees have increased from today, by around 25% and further guidance has now been provided on how the new fees will apply....
In this article, we set out the key aspects for innovators and applicants to consider when patenting gene editors in Europe....
GJE is proud to learn that Peter Arrowsmith, Arnie Clarke and Lucy Samuels have been named as Patent Stars in the IP Stars 2025 rankings....
In Generics, Teva & Glenmark v AstraZeneca, the High Court restated how inventive step and sufficiency are assessed in the UK considering “plausibility”...
Artificial intelligence (AI) is revolutionising the healthcare industry by enhancing our ability to accurately diagnose diseases and predict patient risk factors, and accelerating drug discovery and d...
Read our February 2025 trade mark law and practice update, including updates from the UK, the EU and worldwide...
UPC asserts its jurisdiction in infringement cases even where alleged infringement takes place in a non-UPC member state...